290: Experience with levosimendan as an alternative to catecholamines in children  by Alsohim, Fahad et al.
© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2013) 5, 90-101 97
Introduction: Transient elastography is a rapid, noninvasive and reproduc-
ible approach to assess liver fibrosis by measuring liver stiffness (LS). How-
ever, because the liver is enveloped by a capsule, any variation in
parenchymal fluid content could theoretically affect LS. LS has been corre-
lated to central venous pressure (CVP) in an animal model. We aimed to
determine the correlation between LS and CVP in children and adults with
congenital heart disease.
Methods: In this ongoing prospective study, all patients referred for right
heart catheterization were included. Measurements of mean right atrial pres-
sure were obtained under general anesthesia (Fi02=21%) using an Optitorque
5 French catheter. The patients underwent 10 LS measurements (median value
taken as representive) by transient elastography (Fibroscanâ, Echosens,
France) within the 24 hours before catheterization. The results of LS are
expressed in kilopascals (kPa).
Results: Eleven children (mean age=8±6 yo, 54% male) and 6 adults
(mean age=34±17 yo, 66% male) have been included so far. Catheterism indi-
cations were pulmonary angioplasty (n=5), Melody valve implantation (n=1),
fenestration occlusion after a Fontan procedure (n=1) and pre operative asses-
sement of a complex congenital heart defect (n=10). Mean right atrial pressure
was 9,1±3,9 mmHg and mean LS was 8,4±4,2 kPa. Correlation between LS
and mean right atrial pressure was excellent for these first 17 patients (r=0,87).
Conclusion: Liver stiffness is a new, rapid and reliable method to evaluate
CVP in patients with congenital heart disease. This non invasive parameter
could potentially be usefull for patients in whom CVP play a key role, espe-
cially in patients with a Fontan circulation.
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Introduction: The use of COAGUCHEK XS® (Roche Diagnostics), an
INR home measuring device, was authorised by the French Health High
Authority on June 2008 for children. Nevertheless, there are few data on
safety and effectiveness of patients self management particularly in children.
Methods: Since 2008, 23 children (mean age: 9 y; 16 males, 7 females)
and their families were trained to INR self testing and self management of
vitamin K antagonists (VKA) (acenocoumarol: n=10, fluindione : n=9, war-
farin: n=4). INR controls (self testing or lab) were made at expected dates
established by the french law. Additional measurements were authorised in
risky situations (illness, hyperthermia, forgetting VKA treatment, bleeding,
etc…). Drug dose adaptation was made either by the family or by the health
team if needed.
Objectives: To evaluate safety and efficacy in families performing self
management in our centre. Time in therapeutic range (TTR), severe haemor-
rhage (needing hospitalization and/or blood transfusion) and thrombosis recur-
rence were observed.
Results: Mean follow-up time was 529 days [1.5 y; range 0.3-2.5y]. Mean
TTR was 68.53% and was 90.14% when tolerance range was applied. There
was no severe haemorrhage or thrombosis recurrence during follow-up and
INR >5 were 0.5% (8/1604 measurements). Lastly, 3.5% additional measure-
ments were performed by the families.
Conclusion: VKA self management using COAGUCHEK XS® was safe
and effective in our centre. Clinical studies with larger sample and cost-effec-
tiveness considerations are required.
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The objective of this study was to report experience with levosimendan in
hemodynamically compromised children.
Material and methods: all patients aged < 18years with severe myo-
cardial dysfunction and dependent on inotrope support, who received levosi-
mendan infusion, were reviewed for clinical, biological and echocardiographic
(LV diameters, shortening fraction, sub-aortic Velocity Time Integral) data.
Levosimendan was administered as a continuous intravenous infusion over
24 hours, starting 0.1 micrograms per kg per mn and increased up to
0.2micrograms per kg per mn. Blood pressure and heart rate were continu-
ously monitored, ECG and Echocardiography recorded before, 3 and 5 days
after starting levosimendan.
Results: From 2007 to 2011, 8 patients aged 3.5 months to 13years (mean
41months) received 10 courses of levosimendan. All were on milrinone sup-
port (mean dose 0.63 mcg/kg/mn) and 3 on associated dobutamine. All
achieved the 24-hour course of levosimendan without any complication. Cat-
echolamines were successfully discontinued in 5 cases (3 weaned off at 24th
hour and 2 at 5th day). Average milrinone dose dropped to 0.3 mcg/kg/mn at
day-5, p=0.028). mean shortening fraction increased from 10.8%±1.8 before
to 12.7± 2.3 at day-3 (p= 0.67), mean Velocity Time Integral from 6±0.6 to
8.7±1.2 cm at day-3 (p= 0.04). 
Five patients (62.5%) were successfully discharged from CICU: 2 are
doing well at 1 and 4.5 years follow-up, 1 died from metabolic disease and
2 were readmitted at 1.5 – and 2-month interval and received a second course
of levosimendan. The latter 2 patients did not improve and needed mechanical
ventricular assistance (1 died and 1 underwent successful heart transplanta-
tion). For the remaining 3 patients, first course levosimendan failed and heart
transplantation was performed in an emergency setting (pretransplant mechan-
ical ventricular support in 2).
Conclusion: This small size sample study shows encouraging results of
levosimendan in children with uncontrolled myocardial dysfunction. Further
studies are needed to assess monitoring, timing and indications for repeated
dose infusion during follow-up.
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Background: Congenital heart defects are often diagnosed in infancy, or
even before birth. But some anomalies are harder to detect than others and
may not be diagnosed until much later in childhood or even adulthood. In
developing countries many congenital heart diseases are detected in adult-
hood.
Objective: The aim of this study was to investigate the epidemiology, clin-
ical aspects, diagnosis and treatment of congenital heart disease screened at
adulthood.
Methods: This is a retrospective cohort by medical records analysis
enrolled between January 2010 and March 2012 in one center. We investi-
gated patients with congenital heart diseases aged over 16 years. All patients
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